메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Derakhshan Ali Reza (School of Persian and Complementary Medicine Mashhad University of Medical Sciences Mashhad Iran) Saeidinejat Shahin (Social Determinants of Health Research Center Health School Mashhad University of Medical Sciences) Khadem-Rezaiyan Majid (Department of Community Medicine and Public Health Faculty of Medicine Mashhad University of Medica) Asnaashari Amir-Mohammad-Hashem (Lung Disease Research Center Faculty of Medicine Mashhad University of Medical Sciences Mashhad Ira) Mirsadraee Majid (Department of Internal Medicine Faculty of Medicine Islamic Azad University-Mashhad Branch Mashhad) Salari Roshanak (School of Persian and Complementary Medicine Mashhad University of Medical Sciences Mashhad Iran) Jabbari-Azad Farahzad (Department of Immunology and Allergy Head of Allergy Research Center Ghaem Hospital Mashhad Univers) Jalali Shima (Student Research Committee Mashhad University of Medical Sciences Mashhad Iran) Jalali Shabnam (Student Research Committee Mashhad University of Medical Sciences Mashhad Iran)
저널정보
대한약침학회 Journal of Pharmacopuncture Journal of Pharmacopuncture 제25권 제3호
발행연도
2022.9
수록면
233 - 241 (9page)
DOI
10.3831/KPI.2022.25.3.233

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: Asthma is a chronic disease, and the demand for herbal medicines in this field has increased in recent years. The new findings highlight the role of the gut-lung axis in the pathophysiology of asthma. Hence, this study will evaluate the safety and efficacy of Glasthma syrup, an herbal formula based on Persian medicine, in improving asthma and regulating intestinal permeability. The formula consists of five herbal ingredients that have anti-inflammatory effects on the respiratory tract, also known as gut tonics. Methods: The study will be conducted as a placebo-controlled, triple-blind, randomized trial. It will consist of a 4-week intervention followed by a 4-week follow-up period. The target sample size is 20 patients with moderate asthma aged 18 to 60 years. Eligible participants will be randomly assigned to either the experimental group or the control group in equal numbers. Patients in the experimental group will take Glasthma syrup (7.5 mL, twice a day), while patients in the control group will take a matching placebo. Both groups will receive a 4-week combination of a long-acting beta2 agonist and a leukotriene modulator as standard of care. Inhaled corticosteroids can be used as rescue medication as needed. Results: The primary outcomes are asthma symptom scale, lung function, and intestinal permeability. Secondary outcomes include quality of life, symptom recurrence rates, and blood tests. A safety assessment will also be conducted during the trial. Conclusion: In this trial, the effects of Glasthma syrup in patients with moderate asthma will be examined. The study will also assess the effects of the formulation on the gut-lung axis by simultaneously monitoring the gut permeability index, asthma symptoms, and lung function.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0